首页> 外国专利> INHALABLE LIDOCAINE FORMULATION FOR TREATMENT OF ASTHMA AND FOR REDUCING THE NEED FOR CORTICOSTEROIDS IN ASTHMATIC PATIENTS

INHALABLE LIDOCAINE FORMULATION FOR TREATMENT OF ASTHMA AND FOR REDUCING THE NEED FOR CORTICOSTEROIDS IN ASTHMATIC PATIENTS

机译:吸入性利多卡因制剂用于治疗哮喘和减少哮喘患者中糖皮质激素的需求

摘要

An inhalable lidocaine solution for treatment of asthma and a method for treatment of asthma with the reduced need for concurrent administration of oral corticosteroids in asthmatic patients. The lidocaine solution or lidocaine dry powder is delivered by an electronic nebulizer or by dry powder inhaler or dose meter one to several times a day.
机译:一种用于治疗哮喘的可吸入利多卡因溶液和一种用于治疗哮喘的方法,其减少了哮喘患者同时口服皮质类固醇的需求。利多卡因溶液或利多卡因干粉每天通过电子喷雾器或干粉吸入器或剂量计输送一到几次。

著录项

  • 公开/公告号WO2006036181A1

    专利类型

  • 公开/公告日2006-04-06

    原文格式PDF

  • 申请/专利权人 CORUS PHARMA INC.;

    申请/专利号WO2005US03327

  • 申请日2005-01-28

  • 分类号A61K9/12;A61K9/14;A61K31/24;A61K31/47;

  • 国家 WO

  • 入库时间 2022-08-21 21:31:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号